HLA-B*51 the primary risk in Behçet disease
- 29 May 2014
- journal article
- editorial
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 111 (24), 8706-8707
- https://doi.org/10.1073/pnas.1407307111
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- An NKG2D-Mediated Human Lymphoid Stress Surveillance Response with High Interindividual VariationScience Translational Medicine, 2011
- Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility lociNature Genetics, 2010
- The Yin and Yang of HLA and KIR in human diseaseSeminars in Immunology, 2008
- Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individualsGenes & Immunity, 2008
- In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib moleculesThe Journal of Experimental Medicine, 2006
- Behcet's disease: from Hippocrates to the third millenniumBritish Journal of Ophthalmology, 2003
- Localization of the pathogenic gene of Behçet's disease by microsatellite analysis of three different populations.2000
- MIC-A allele profiles and HLA class I associations in Behçet's diseaseImmunogenetics, 1999
- Triplet repeat polymorphism in the transmembrane region of the MICA gene: A strong association of six GCT repetitions with Behçet diseaseProceedings of the National Academy of Sciences of the United States of America, 1997
- Close Association of HLA-Bw51 With Behcet's DiseaseAmerican Journal of Ophthalmology, 1982